ATE301995T1 - Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen - Google Patents
Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzenInfo
- Publication number
- ATE301995T1 ATE301995T1 AT01968030T AT01968030T ATE301995T1 AT E301995 T1 ATE301995 T1 AT E301995T1 AT 01968030 T AT01968030 T AT 01968030T AT 01968030 T AT01968030 T AT 01968030T AT E301995 T1 ATE301995 T1 AT E301995T1
- Authority
- AT
- Austria
- Prior art keywords
- valproic acid
- pain
- prevention
- derivatives
- treatment
- Prior art date
Links
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical class CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 title abstract 3
- 208000002193 Pain Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 229960000604 valproic acid Drugs 0.000 title abstract 2
- 206010019233 Headaches Diseases 0.000 title 1
- 208000027109 Headache disease Diseases 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22597300P | 2000-08-17 | 2000-08-17 | |
| US22597700P | 2000-08-17 | 2000-08-17 | |
| PCT/US2001/025919 WO2002013766A2 (en) | 2000-08-17 | 2001-08-17 | Valproic acid derivatives for the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE301995T1 true ATE301995T1 (de) | 2005-09-15 |
Family
ID=26920105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01968030T ATE301995T1 (de) | 2000-08-17 | 2001-08-17 | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20020052418A1 (de) |
| EP (1) | EP1311256B1 (de) |
| JP (1) | JP2004505999A (de) |
| KR (1) | KR100851955B1 (de) |
| CN (1) | CN100462069C (de) |
| AT (1) | ATE301995T1 (de) |
| AU (1) | AU8830801A (de) |
| CA (1) | CA2418455A1 (de) |
| CZ (1) | CZ2004362A3 (de) |
| DE (1) | DE60112766T2 (de) |
| DK (1) | DK1311256T3 (de) |
| ES (1) | ES2245377T3 (de) |
| HU (1) | HUP0401867A2 (de) |
| IL (2) | IL154470A0 (de) |
| MX (1) | MXPA03001458A (de) |
| NO (1) | NO20030724D0 (de) |
| NZ (1) | NZ524687A (de) |
| PL (1) | PL363041A1 (de) |
| SI (1) | SI1311256T1 (de) |
| WO (1) | WO2002013766A2 (de) |
| ZA (1) | ZA200301427B (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1243262E (pt) * | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
| EP1243263B1 (de) * | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen |
| US20040175423A1 (en) * | 2003-02-05 | 2004-09-09 | Daniella Licht | Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compounds |
| US20040176463A1 (en) * | 2003-02-05 | 2004-09-09 | Daniella Licht | Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
| IL157751A0 (en) * | 2003-02-28 | 2004-03-28 | Yissum Res Dev Co | New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them |
| EP1491188A1 (de) * | 2003-06-25 | 2004-12-29 | G2M Cancer Drugs AG | Topische Verwendung von Valproinsäure zur Behandlung von Hauterkrankungen |
| US20060004098A1 (en) * | 2003-07-28 | 2006-01-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compounds useful for treating neurological disorders |
| ES2325995T3 (es) * | 2003-12-02 | 2009-09-28 | Schwarz Pharma Ag | Nueva utilizacion de compuestos peptidicos para tratamiento del dolor neuropatico central. |
| US20060009384A1 (en) * | 2003-12-05 | 2006-01-12 | David Rudd | Novel use of peptide compounds for treating status epilepticus or related conditions |
| US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
| US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
| EP1579858A1 (de) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von diabetishen Neuropathie |
| JP2007532607A (ja) * | 2004-04-16 | 2007-11-15 | シュバルツ ファルマ アクチェンゲゼルシャフト | 慢性頭痛の予防及び治療のためのペプチド化合物の使用 |
| EP1604655A1 (de) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von Trigeminusneuralgie |
| US7427601B2 (en) * | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
| US20060025477A1 (en) * | 2004-07-22 | 2006-02-02 | Artman Linda D | Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
| BRPI0514721A (pt) | 2004-08-27 | 2008-06-24 | Sanol Arznei Schwarz Gmbh | uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo |
| EP1642889A1 (de) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Verbessertes Syntheseschema für Lacosamid |
| US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
| US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| EP1754476A1 (de) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie |
| ES2531118T5 (es) | 2006-06-15 | 2022-06-14 | Ucb Pharma Gmbh | Composición farmacéutica que comprende lacosamida y levetiracetamo para uso en el tratamiento de la epilepsia |
| CN101466390B (zh) | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
| EP1873527A1 (de) * | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Verfahren zur Identifizierung von CRMP-Modulatoren |
| ES2326355B1 (es) * | 2008-02-25 | 2010-08-10 | Centro Atlantico Del Medicamento, S.A. | Acido 1-(di-n-propilacetilaminometil)-ciclohexilacetico. |
| KR101733189B1 (ko) * | 2010-10-06 | 2017-05-08 | (주)아모레퍼시픽 | 손톱 또는 발톱 성장 촉진용 조성물 |
| EP2468261A1 (de) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulierung von Lacosamid |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3010599A1 (de) * | 1979-03-22 | 1980-10-09 | Continental Pharma | Derivate von glycinamid, deren herstellung und verwendung |
| US4301176A (en) * | 1980-08-18 | 1981-11-17 | Warner-Lambert Company | Method of administering calcium valproate |
| LU83729A1 (fr) * | 1981-11-04 | 1983-09-01 | Galephar | Sels d'acide valproique,leur preparation et leur utilisation |
| US4913906B1 (en) * | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
| US5169642A (en) * | 1988-06-24 | 1992-12-08 | Abbott Laboratories | Sustained-release drug dosage units |
| US6287598B1 (en) * | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
| US5585358A (en) * | 1993-07-06 | 1996-12-17 | Yissum Research Development Corporation Of The Hebrew University Of Jerusalem | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
| UA48219C2 (uk) * | 1996-03-25 | 2002-08-15 | Елі Ліллі Енд Компані | Композиція для вгамування болю (варіанти) та спосіб вгамування болю |
| CA2264577A1 (en) * | 1996-08-30 | 1998-03-05 | Nps Pharmaceuticals, Inc. | Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
| IL121268A0 (en) * | 1997-07-09 | 1998-01-04 | Dpharm Ltd | Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders |
| US5760007A (en) * | 1997-07-16 | 1998-06-02 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating neuropathic pain |
| HUP0102456A3 (en) * | 1998-06-22 | 2003-07-28 | American Biogenetic Sciences | The use of valproic acid analog for the treatment and prevention of migraine and affective illness |
| CZ20012620A3 (cs) * | 1999-01-19 | 2002-09-11 | Ortho-Mcneil Pharmaceutical, Inc. | Léčivo pro léčení histaminové cefalalgie |
-
2001
- 2001-08-17 EP EP01968030A patent/EP1311256B1/de not_active Expired - Lifetime
- 2001-08-17 IL IL15447001A patent/IL154470A0/xx unknown
- 2001-08-17 JP JP2002518914A patent/JP2004505999A/ja active Pending
- 2001-08-17 HU HU0401867A patent/HUP0401867A2/hu unknown
- 2001-08-17 CN CNB018171346A patent/CN100462069C/zh not_active Expired - Fee Related
- 2001-08-17 KR KR1020037002061A patent/KR100851955B1/ko not_active Expired - Fee Related
- 2001-08-17 CA CA002418455A patent/CA2418455A1/en not_active Abandoned
- 2001-08-17 US US09/932,370 patent/US20020052418A1/en not_active Abandoned
- 2001-08-17 AT AT01968030T patent/ATE301995T1/de not_active IP Right Cessation
- 2001-08-17 ES ES01968030T patent/ES2245377T3/es not_active Expired - Lifetime
- 2001-08-17 DE DE60112766T patent/DE60112766T2/de not_active Expired - Lifetime
- 2001-08-17 DK DK01968030T patent/DK1311256T3/da active
- 2001-08-17 NZ NZ524687A patent/NZ524687A/en unknown
- 2001-08-17 WO PCT/US2001/025919 patent/WO2002013766A2/en not_active Ceased
- 2001-08-17 AU AU8830801A patent/AU8830801A/xx not_active Withdrawn
- 2001-08-17 PL PL01363041A patent/PL363041A1/xx not_active Application Discontinuation
- 2001-08-17 MX MXPA03001458A patent/MXPA03001458A/es active IP Right Grant
- 2001-08-17 CZ CZ2004362A patent/CZ2004362A3/cs unknown
- 2001-08-17 SI SI200130418T patent/SI1311256T1/sl unknown
-
2003
- 2003-02-14 NO NO20030724A patent/NO20030724D0/no not_active Application Discontinuation
- 2003-02-14 IL IL154470A patent/IL154470A/en not_active IP Right Cessation
- 2003-02-21 ZA ZA200301427A patent/ZA200301427B/en unknown
-
2004
- 2004-04-16 US US10/826,904 patent/US20040204495A1/en not_active Abandoned
-
2009
- 2009-06-24 US US12/457,875 patent/US8288442B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PL363041A1 (en) | 2004-11-15 |
| AU8830801A (en) | 2002-02-25 |
| JP2004505999A (ja) | 2004-02-26 |
| ZA200301427B (en) | 2004-02-23 |
| EP1311256A2 (de) | 2003-05-21 |
| WO2002013766A2 (en) | 2002-02-21 |
| DE60112766D1 (de) | 2005-09-22 |
| SI1311256T1 (sl) | 2005-12-31 |
| WO2002013766A3 (en) | 2002-06-20 |
| CZ2004362A3 (cs) | 2005-01-12 |
| US20090281045A1 (en) | 2009-11-12 |
| EP1311256A4 (de) | 2004-03-24 |
| DK1311256T3 (da) | 2005-11-28 |
| IL154470A0 (en) | 2003-09-17 |
| KR100851955B1 (ko) | 2008-08-12 |
| DE60112766T2 (de) | 2006-03-30 |
| CA2418455A1 (en) | 2002-02-21 |
| US8288442B2 (en) | 2012-10-16 |
| US20020052418A1 (en) | 2002-05-02 |
| NO20030724L (no) | 2003-02-14 |
| US20040204495A1 (en) | 2004-10-14 |
| EP1311256B1 (de) | 2005-08-17 |
| IL154470A (en) | 2010-11-30 |
| NZ524687A (en) | 2005-01-28 |
| CN1551762A (zh) | 2004-12-01 |
| CN100462069C (zh) | 2009-02-18 |
| NO20030724D0 (no) | 2003-02-14 |
| MXPA03001458A (es) | 2004-05-04 |
| KR20030036691A (ko) | 2003-05-09 |
| ES2245377T3 (es) | 2006-01-01 |
| HUP0401867A2 (hu) | 2004-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE301995T1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
| BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
| DE69936102D1 (de) | Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden | |
| NO20061736L (no) | Krystallform av epotilon B | |
| EE200100485A (et) | Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena | |
| EA200500169A1 (ru) | Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение | |
| IS7925A (is) | Hýdroxýetýlamínafleiður til að meðhöndla Alzheimers-sjúkdóm | |
| ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
| TR200402230T4 (tr) | O-ikameli 6-metil-tramadol-türevleri | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| MXPA04000272A (es) | Derivados de 4-aminociclohexanol sustituidos. | |
| DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
| SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
| DE602004016841D1 (de) | Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen | |
| ATE482217T1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| DE60137506D1 (de) | Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose | |
| ATE318594T1 (de) | Verwendung von treosulfan und derivaten davon zur behandlung der multiplen sklerose | |
| DE602004025001D1 (de) | Verbindungen zur behandlung von neuropathischen schmerzen und migräne | |
| ATE355834T1 (de) | Verwendung von 4-oxo-butansäure derivaten zur behandlung der entzündung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1311256 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |